NCT05351476

Brief Summary

Adipose tissue turnover plays a critical role in body weight maintenance, and obesity is underscored by the dysregulated balance between fat breakdown and synthesis. Although there are clear health-related benefits of physical activity, little is known about how resistance exercise, as opposed to endurance exercise, can reduce the risk of metabolic disorders, particularly in women. The goal of the proposed study is to investigate the effectiveness of resistance training to improve basal and stimulated fat metabolism in postmenopausal women with obesity and pre-diabetes, potentially serving as a viable and practical approach to prevent the onset of type 2 diabetes.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
12mo left

Started May 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress80%
May 2022Apr 2027

First Submitted

Initial submission to the registry

April 4, 2022

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 28, 2022

Completed
22 days until next milestone

Study Start

First participant enrolled

May 20, 2022

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2027

Last Updated

April 13, 2026

Status Verified

April 1, 2026

Enrollment Period

4.9 years

First QC Date

April 4, 2022

Last Update Submit

April 7, 2026

Conditions

Keywords

Resistance ExerciseFat MetabolismPostmenopause

Outcome Measures

Primary Outcomes (3)

  • Change from baseline subcutaneous abdominal adipose tissue glycerol concentration at 12 weeks

    Changes in physical activity (walking)-stimulated lipolysis will be assessed as measured by glycerol concentration in dialysate samples from subcutaneous abdominal adipose tissue utilizing a powerful in-vivo microdialysis methodology

    12 weeks of resistance or endurance training

  • Change from baseline gluteal adipose tissue glycerol concentration at 12 weeks

    Changes in physical activity (walking)-stimulated lipolysis will be assessed as measured by glycerol concentration in dialysate samples from gluteal adipose tissue utilizing a powerful in-vivo microdialysis methodology

    12 weeks of resistance or endurance training

  • Change from baseline whole-body lipolysis at 12 weeks

    Whole body lipolysis will be measured using whole body rate of appearance of 2H5-glycerol in blood samples collected at rest, during walking exercise, and for 120 minutes after exercise.

    12 weeks of resistance or endurance training

Secondary Outcomes (7)

  • Change in blood flow as measured by ethanol concentrations in dialysate samples from subcutaneous abdominal adipose tissue

    12 weeks of resistance or endurance training

  • Change in dialysate ethanol data in subcutaneous gluteal adipose tissue

    12 weeks of resistance or endurance training

  • Change in the ratio of 13CO2 to 12CO2 in breath samples

    12 weeks of resistance or endurance training

  • change in body composition

    12 weeks of resistance or endurance training

  • Change in blood growth hormone concentrations

    12 weeks of resistance or endurance training

  • +2 more secondary outcomes

Study Arms (2)

Resistance Exercise

EXPERIMENTAL

Participants do regular resistance exercise for 12 weeks.

Behavioral: Resistance Exercise

Endurance Exercise

EXPERIMENTAL

Participants do regular endurance exercise for 12 weeks.

Behavioral: Endurance Exercise

Interventions

200 Kcal worth of weightlifting, 3 times/week for 12 weeks

Also known as: Weight Lifting
Resistance Exercise

200 Kcal worth of treadmill walking, 3 times/week for 12 weeks

Also known as: Aerobic Exercise
Endurance Exercise

Eligibility Criteria

Age50 Years - 75 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women
  • Postmenopausal (50-75 yrs.)
  • Obese (BMI 30-50 kg/m2)
  • Prediabetes (HbA1c 5.7 - 6.4% or fasting blood glucose 100 to 125 mg/dL, or 2hr OGTT blood glucose 140 to 199 mg/dL)
  • Sedentary (not performing purposeful exercise training more than 20 minutes per day twice a week)
  • Non-smokers
  • No hormone replacement therapy for at least the past two years.

You may not qualify if:

  • Engaging in purposeful resistance training or endurance training (\> 20min/day, \> 2 days/week)
  • Resting blood pressure above 140 mmHg systolic or 90 mmHg diastolic
  • Type 1 or type 2 diabetes
  • Medical problems in which exercise is contraindicated, such as chronic infections
  • History of, or currently presentation with, cancer, cardiovascular or respiratory disease
  • Uncontrolled thyroid dysfunction, liver or renal dysfunction
  • Taking any medication affecting lipid metabolism
  • Musculoskeletal disease or injury that would otherwise prevent engagement in resistance and endurance training
  • Smokers and those with diagnosed eating disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida State University

Tallahassee, Florida, 32306, United States

RECRUITING

Related Publications (13)

  • Bonafiglia JT, Rotundo MP, Whittall JP, Scribbans TD, Graham RB, Gurd BJ. Inter-Individual Variability in the Adaptive Responses to Endurance and Sprint Interval Training: A Randomized Crossover Study. PLoS One. 2016 Dec 9;11(12):e0167790. doi: 10.1371/journal.pone.0167790. eCollection 2016.

    PMID: 27936084BACKGROUND
  • Kim J, Wang Z, Heymsfield SB, Baumgartner RN, Gallagher D. Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method. Am J Clin Nutr. 2002 Aug;76(2):378-83. doi: 10.1093/ajcn/76.2.378.

    PMID: 12145010BACKGROUND
  • Hopkins WG. Measures of reliability in sports medicine and science. Sports Med. 2000 Jul;30(1):1-15. doi: 10.2165/00007256-200030010-00001.

    PMID: 10907753BACKGROUND
  • Culver AL, Ockene IS, Balasubramanian R, Olendzki BC, Sepavich DM, Wactawski-Wende J, Manson JE, Qiao Y, Liu S, Merriam PA, Rahilly-Tierny C, Thomas F, Berger JS, Ockene JK, Curb JD, Ma Y. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med. 2012 Jan 23;172(2):144-52. doi: 10.1001/archinternmed.2011.625. Epub 2012 Jan 9.

    PMID: 22231607BACKGROUND
  • Kim JY, Hickner RC, Cortright RL, Dohm GL, Houmard JA. Lipid oxidation is reduced in obese human skeletal muscle. Am J Physiol Endocrinol Metab. 2000 Nov;279(5):E1039-44. doi: 10.1152/ajpendo.2000.279.5.E1039.

    PMID: 11052958BACKGROUND
  • Hickner RC, Racette SB, Binder EF, Fisher JS, Kohrt WM. Suppression of whole body and regional lipolysis by insulin: effects of obesity and exercise. J Clin Endocrinol Metab. 1999 Nov;84(11):3886-95. doi: 10.1210/jcem.84.11.6137.

    PMID: 10566624BACKGROUND
  • Hickner RC, Racette SB, Binder EF, Fisher JS, Kohrt WM. Effects of 10 days of endurance exercise training on the suppression of whole body and regional lipolysis by insulin. J Clin Endocrinol Metab. 2000 Apr;85(4):1498-504. doi: 10.1210/jcem.85.4.6550.

    PMID: 10770188BACKGROUND
  • Sial S, Coggan AR, Hickner RC, Klein S. Training-induced alterations in fat and carbohydrate metabolism during exercise in elderly subjects. Am J Physiol. 1998 May;274(5):E785-90. doi: 10.1152/ajpendo.1998.274.5.E785.

    PMID: 9612234BACKGROUND
  • Hickner RC, Rosdahl H, Borg I, Ungerstedt U, Jorfeldt L, Henriksson J. The ethanol technique of monitoring local blood flow changes in rat skeletal muscle: implications for microdialysis. Acta Physiol Scand. 1992 Sep;146(1):87-97. doi: 10.1111/j.1748-1716.1992.tb09396.x.

    PMID: 1442130BACKGROUND
  • Pierce JR, Maples JM, Hickner RC. IL-15 concentrations in skeletal muscle and subcutaneous adipose tissue in lean and obese humans: local effects of IL-15 on adipose tissue lipolysis. Am J Physiol Endocrinol Metab. 2015 Jun 15;308(12):E1131-9. doi: 10.1152/ajpendo.00575.2014. Epub 2015 Apr 28.

    PMID: 25921578BACKGROUND
  • Gavin KM, Cooper EE, Raymer DK, Hickner RC. Estradiol effects on subcutaneous adipose tissue lipolysis in premenopausal women are adipose tissue depot specific and treatment dependent. Am J Physiol Endocrinol Metab. 2013 Jun 1;304(11):E1167-74. doi: 10.1152/ajpendo.00023.2013. Epub 2013 Mar 26.

    PMID: 23531620BACKGROUND
  • Ormsbee MJ, Choi MD, Medlin JK, Geyer GH, Trantham LH, Dubis GS, Hickner RC. Regulation of fat metabolism during resistance exercise in sedentary lean and obese men. J Appl Physiol (1985). 2009 May;106(5):1529-37. doi: 10.1152/japplphysiol.91485.2008. Epub 2009 Mar 5.

    PMID: 19265063BACKGROUND
  • Ormsbee MJ, Clapper JA, Clapper JL, Vukovich MD. The impact of varying dietary protein on serum IGF-I, IGFBP-1, and IGFBP-3 during 6 days of physical activity. Int J Sport Nutr Exerc Metab. 2007 Apr;17(2):127-39. doi: 10.1123/ijsnem.17.2.127.

    PMID: 17507738BACKGROUND

MeSH Terms

Conditions

ObesityPrediabetic State

Interventions

Resistance TrainingExercise

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsDiabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Exercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Robert C Hickner, PhD

    Florida State University

    PRINCIPAL INVESTIGATOR
  • Michael J Ormsbee, PhD

    Florida State University

    PRINCIPAL INVESTIGATOR
  • Mostafa M Ali, PhD

    Florida State University

    STUDY DIRECTOR

Central Study Contacts

Robert C Hickner, PhD

CONTACT

Michael J Ormsbee, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 4, 2022

First Posted

April 28, 2022

Study Start

May 20, 2022

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

April 30, 2027

Last Updated

April 13, 2026

Record last verified: 2026-04

Locations